Fosun Pharma’s Q1–Q3 2025 results: clear growth in innovative drugs and a planned vaccine spin‑offChina Finance China Startups Tech in ChinaFosun Pharma, Fuxing Antejin, Healthcare, Pharmaceuticals October 29, 2025